The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,7,9-trimethyl-6-[tetradec-1-enyl]-3,4-dihydroquinolizin-5-ium ID: ALA4641650
PubChem CID: 156016084
Max Phase: Preclinical
Molecular Formula: C26H42N+
Molecular Weight: 368.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCC/C=C/c1c(C)cc(C)c2[n+]1CC(C)C=C2
Standard InChI: InChI=1S/C26H42N/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-25-23(3)20-24(4)26-19-18-22(2)21-27(25)26/h16-20,22H,5-15,21H2,1-4H3/q+1/b17-16+
Standard InChI Key: YVDOFDBWEXOBCV-WUKNDPDISA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
17.0319 -21.9999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0307 -22.8273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4591 -21.9963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7437 -21.5872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4620 -22.8268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7420 -23.2372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7375 -24.0614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4512 -24.4814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1712 -24.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1774 -23.2405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3161 -23.2395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7413 -20.7622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1720 -21.5811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1689 -20.7561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8819 -20.3409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5978 -20.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3108 -20.3355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0267 -20.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8830 -24.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7397 -20.3302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4557 -20.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1686 -20.3247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8846 -20.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5975 -20.3194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3135 -20.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0265 -20.3140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7425 -20.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
2 11 1 0
4 12 1 0
3 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
9 19 1 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M CHG 1 5 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.63Molecular Weight (Monoisotopic): 368.3312AlogP: 7.58#Rotatable Bonds: 12Polar Surface Area: 3.88Molecular Species: NEUTRALHBA: ┄HBD: ┄#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.40CX LogD: 4.40Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.26Np Likeness Score: 0.81
References 1. Nakagawa Y, Sawaki Y, Miyanishi W, Shimomura S, Shibata T, Ojika M.. (2020) Relationship among structure, cytotoxicity, and Michael acceptor reactivity of quinocidin., 28 (4): [PMID:31956051 ] [10.1016/j.bmc.2020.115308 ]